Pictet Asset Management Holding Sa Crispr Therapeutics Ag Transaction History
Pictet Asset Management Holding Sa
- $86.3 Billion
- Q1 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 246,086 shares of CRSP stock, worth $9.36 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
246,086
Previous 272,704
9.76%
Holding current value
$9.36 Million
Previous $10.7 Million
21.98%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding CRSP
# of Institutions
479Shares Held
64.2MCall Options Held
2.15MPut Options Held
1.92M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$387 Million3.73% of portfolio
-
Capital International Investors Los Angeles, CA6.07MShares$231 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$144 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$106 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.54MShares$96.6 Million1.16% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $2.97B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....